SCHEMBL1100231

SCHEMBL1100231

CCS(=O)(=O)N(CCSC)c1sc2ccccc2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.39
HSD11B1 P28845 1/20 0.36
PTPN1 P18031 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 5/20 0.32
MAPT P10636 4/20 0.32
LMNA P02545 2/20 0.32
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
APP P05067 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099202 0.85 TRPM8 (0.48) TRPM8HSD11B1LMNAKDM4E
SCHEMBL1100720 0.82 ALDH1A1 (0.44) TRPM8HSD11B1ALDH1A1MAPTRAB9A
SCHEMBL1099130 0.81 TRPM8 (0.43) TRPM8HSD11B1PTPN1ALDH1A1MAPT
SCHEMBL1099978 0.80 TRPM8 (0.37) TRPM8HSD11B1PTPN1ATMALDH1A1
SCHEMBL1099356 0.79 TRPM8 (0.40) TRPM8HSD11B1PTPN1ALDH1A1MAPT
SCHEMBL1098846 0.78 TRPM8 (0.40) TRPM8HSD11B1L3MBTL1ATMALDH1A1
SCHEMBL1100085 0.77 TRPM8 (0.41) TRPM8HSD11B1L3MBTL1ATMALDH1A1
SCHEMBL1099760 0.76 TRPM8 (0.39) TRPM8HSD11B1PTPN1ATMMEN1
SCHEMBL1100105 0.76 TRPM8 (0.43) TRPM8ALDH1A1MAPTLMNARAB9A
SCHEMBL1098884 0.72 TRPM8 (0.43) TRPM8HSD11B1ALDH1A1LMNAPRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885PTPN1 3310/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885PTPN1 3310/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885PTPN1 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.